Provided by Tiger Trade Technology Pte. Ltd.

Global X Aging Population ETF

37.04
+0.14420.39%
Volume:2K
Turnover:57.55K
Market Cap:91.47M
PE:- -
High:37.08
Open:36.95
Low:36.95
Close:36.89
52wk High:39.48
52wk Low:32.44
Shares:2.47M
Float Shares:2.47M
Volume Ratio:0.19
T/O Rate:0.06%
Dividend:0.33
Dividend Rate:0.89%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Yesterday

Sector Update: Healthcare

MT Newswires Live
·
Yesterday

Circle Pharma Raises $92.5 Million in Series E Funding Led by Column Group

Reuters
·
Yesterday

Twist Bioscience Corporation - to Provide Antibody Characterization Data Services for Lilly Tunelab

THOMSON REUTERS
·
Yesterday

Circle Pharma: Financing Led by Column Group, Participation from Nextech Invest, Ra Capital Management, Strategic Investment from Eli Lilly and Co

THOMSON REUTERS
·
Yesterday

Ulanqab Municipal Market Regulation Bureau Advances Medical Device Quality Control Sampling in 2026

Deep News
·
Yesterday

Actinogen Medical Options Expire, Streamlining ASX-Listed Capital Structure

TIPRANKS
·
Yesterday

Cambium Bio Plans New Share Placement to Bolster Capital Base

TIPRANKS
·
Yesterday

Healthpeak Properties Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Yesterday

Ventas Appoints Laurida Sayed as Chief Accounting Officer

TIPRANKS
·
Yesterday

Thatch Raises $108 Million at $1 Billion Valuation

Reuters
·
Yesterday

Thatch: Funding & Participation from the General Partnership, General Catalyst, Andreessen Horowitz, ADP Ventures, Eli Lilly & Others

THOMSON REUTERS
·
Yesterday

LIVE Markets-from Ozempic Face to K-Beauty Factories: the Next Beauty Bet

Reuters
·
Sep 15

Ventas Coverage Assumed by Jefferies at Buy

Dow Jones
·
Sep 15

Sichuan Shuangma Expands CDMO Operations Into Major Western Markets, Secures Partnerships With Multiple US and European Biotech Firms

Deep News
·
Sep 15

Eli Lilly Stock (LLY) Gets New Buy Rating as Weight-Loss Drug Sales Accelerate

TIPRANKS
·
Sep 15

Abbvie Exec Says Will Present Late-Stage Data for Blood Cancer Drug Etentamig at International Myeloma Society Meeting Later in September - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Existing Portfolio Provides 'Clear Line of Sight' to Very Strong Growth Well into Next Decade - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Apogee Fits 'Very Nicely' with Its Business Development Approach - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Plans to Start Enrolling Apogee's Zumilokibart This Year, Targets Launch in Early 2030 - Conf Call

THOMSON REUTERS
·
Sep 15